Patrick Walsh files to sell 3,973 ANIP shares

Patrick Walsh submitted a Form 144 notice to sell 3,973 shares of Common Stock.

Rhea-AI Filing Summary

Patrick Walsh submitted a Form 144 notice to sell 3,973 shares of Common Stock. The filing lists the securities as restricted stock with an original grant date of 05/21/2025. The filing also reports that 6,000 shares were sold on 03/03/2026 for $445,390.20.

Insights

Equity Capital Markets Compliance

Form 144 reports a proposed Rule 144 resale of restricted shares and prior recent sales.

Form 144 is a regulatory notice that a holder intends to sell restricted or control securities under Rule 144. The filing here lists 3,973 shares proposed for sale and identifies those shares as restricted stock with a grant date of 05/21/2025.

Cash-flow treatment and the distribution method are not stated in the excerpt; prior sales of 6,000 shares on 03/03/2026 for $445,390.20 are reported. Subsequent public filings or broker reports would confirm whether the proposed sale was executed.

Key Figures

Proposed sale: 3,973 shares Recent sale: 6,000 shares Proceeds reported for recent sale: $445,390.20 +1 more

4 metrics

Proposed sale 3,973 shares Restricted stock proposed for sale, grant date 05/21/2025

Recent sale 6,000 shares Sold on 03/03/2026

Proceeds reported for recent sale $445,390.20 Consideration for 6,000 shares sold on 03/03/2026

Grant/issue date 05/21/2025 Grant date for the restricted shares listed for sale

Key Terms

Form 144, Restricted Stock, Issuer

3 terms

Form 144 regulatory

"Form 144 notice to sell restricted securities"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock financial

"Common | 05/21/2025 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Issuer regulatory

"Distribution method field lists 'Issuer' for the securities to be sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Patrick Walsh's Form 144 for ANIP report?

The Form 144 reports an intention to sell 3,973 shares of Common Stock and identifies them as restricted stock with a grant date of 05/21/2025. It also lists prior sales of 6,000 shares on 03/03/2026.

How many ANIP shares were sold in the past three months according to the filing?

The filing shows 6,000 shares were sold on 03/03/2026 for $445,390.20. This is reported under the section listing securities sold during the past three months.

What type of ANIP securities does the Form 144 list for sale?

The filing classifies the shares proposed for sale as restricted stock with an indicated grant/issue date of 05/21/2025. The filing lists the transaction party as Issuer in the distribution method field.

Does the Form 144 state how proceeds will be used or who will receive them?

The excerpt does not specify a use of proceeds or a recipient beyond the listing of the seller. Cash-flow treatment and detailed distribution mechanics are not provided in the provided excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 04:51 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001720568
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ANI Pharmaceuticals, Inc.
SEC File Number	001-31812
Address of Issuer	104 Carnegie Center Drive, Suite 300 Princeton NEW JERSEY 08540
Phone	(609)759-1810
Name of Person for Whose Account the Securities are To Be Sold	PATRICK WALSH
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3973	320819.75	22734618	05/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/21/2025	Restricted Stock	Issuer			3973	05/21/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PATRICK WALSH 104 Carnegie Center Drive, Suite 300 Princeton NJ 08540	Common	03/03/2026	6000	445390.20

144: Remarks and Signature

Remarks
Date of Notice	05/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Patrick Dennis Walsh
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)